Susquehanna International Group’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
55,629
+10,714
| +24% | +$215K | ﹤0.01% | 3086 |
|
|
2025
Q1 | $884K | Buy |
44,915
+29,385
| +189% | +$578K | ﹤0.01% | 3542 |
|
|
2024
Q4 | $349K | Buy |
+15,530
| New | +$349K | ﹤0.01% | 4560 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5857 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5861 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6103 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5762 |
|
|
2023
Q2 | – | Sell |
-17,167
| Closed | -$376K | – | 5863 |
|
|
2023
Q1 | $376K | Buy |
+17,167
| New | +$376K | ﹤0.01% | 4157 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6074 |
|
|
2022
Q3 | – | Sell |
-24,552
| Closed | -$120K | – | 6316 |
|
|
2022
Q2 | $120K | Sell |
24,552
-4,993
| -17% | -$24.4K | ﹤0.01% | 4904 |
|
|
2022
Q1 | $222K | Buy |
29,545
+20,347
| +221% | +$153K | ﹤0.01% | 4694 |
|
|
2021
Q4 | $83K | Buy |
9,198
+6,361
| +224% | +$57.4K | ﹤0.01% | 5345 |
|
|
2021
Q3 | $46K | Buy |
+2,837
| New | +$46K | ﹤0.01% | 5102 |
|